Trial Profile
Jikei Nateglinide and Arbs for Vascular Intervention Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Valsartan (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms J-NAVI
- 10 Aug 2014 Status changed from recruiting to completed as reported by UMIN record.
- 07 May 2008 New trial record.